Market Access focus: The changing landscape of patient access to new medicines

Read this article in our Pf Magazine Market Access Special Edition here.  In a constantly changing market access landscape, industry has a greater range of...

Market Access focus: What does modern market access really mean?

Read this article in our Pf Magazine Market Access Special Edition here.  There is no one definition for modern market access – what does it...

Market Access focus: Where are we now?

Read this article in our Pf Magazine Market Access Special Edition here.  The PM Society Market Access interest group (MAIG) recently conducted a needs analysis...

“Life-changing” developments in the treatment of severe asthma

Asthma is one of the most prevalent long term conditions in the UK, affecting 5.4 million people, of whom nearly three million take treatment....

Duchenne UK works hard to find a cure for DMD

Duchenne UK’s co-founder and joint CEO Emily Crossley shares her vision for finding a cure for Duchenne Muscular Dystrophy (DMD) patients. DMD is a devastating...

What is being done in the fight against ovarian cancer?

  March is Ovarian Cancer Awareness Month. Early detection of this devastating disease is essential. What’s being done? Ovarian cancer kills 11 women every day in...

Hunt hangs on for health and social care future

  Accountability in Health and Social Care, and the incredible unsinkable Health Secretary Earlier this year, Jeremy Hunt somehow survived another Cabinet reshuffle. His ability to...

Tackling antimicrobial resistance: What’s new?

  1. Supercharge me Researchers at the University of Queensland (UQ) in Australia have ‘supercharged’ an old antibiotic using a technique that could potentially lead to the...

Heart-stopping poison – key to a male contraceptive?

  Could a heart-stopping poison hold the key to a male contraceptive pill?   Don’t believe the hype: health headlines dissected     THE...

Are young people excited by a career in industry?

  Breakthroughs, tech and innovation are abundant, but are young people excited by a career in industry? Ask children what they want to do with the...

Latest articles

Pfizer & Lilly announce results of tanezumab trial for osteoarthritis pain

Pfizer Inc. and Eli Lilly and Company have announced that a 16-week Phase 3 study in patients with osteoarthritis (OA) pain evaluating subcutaneous administration...

Vyriad’s colorectal cancer oncolytic virus – Voyager-V1

Vyriad Inc., a clinical-stage, privately held biotechnology company focused on the development of powerful first-in class oncolytic virotherapies, announces a collaboration agreement with Merck...

Kisqali ® is first breast cancer therapy specifically for premenopausal women

Novartis has announced a new approval for Kisqali ® (ribociclib) from the US Food and Drug Administration (FDA) for women with hormone-receptor positive, human...